Early Data Show Ongoing Benefit of Bria-IMT in Small Breast Cancer Population
Title: | Early Data Show Ongoing Benefit of Bria-IMT in Small Breast Cancer Population |
---|---|
Authors: | By:Nicholas Wrigley |
Source: | CancerNetwork (USA), March 20, 2023 News, 3pp |
Abstract: | Targeted immunotherapy agent Bria-IMT (SV-BR-1-GM) continued to yield clinical survival benefit in combination with retifanlimab (MGA012) in 11 patients with advanced, metastatic breast cancer who were enrolled in a phase 1/2 trial (NCT03328026) in 2021 or 2022, according to data published in a press release from BriaCell Therapeutics. Investigators reported a median progression-free survival (PFS) of 3.5 months, with 1 patient who continued to be progression free... |
Database: | NewsBank |
FullText | Text: Availability: 0 |
---|---|
Header | DbId: edsnbk DbLabel: NewsBank An: 190661711D3A4108 RelevancyScore: 625 AccessLevel: 6 PubType: News PubTypeId: newspaperArticle PreciseRelevancyScore: 625 |
IllustrationInfo | |
Items | – Name: Title Label: Title Group: Ti Data: Early Data Show Ongoing Benefit of Bria-IMT in Small Breast Cancer Population – Name: Author Label: Authors Group: Au Data: By:Nicholas Wrigley – Name: TitleSource Label: Source Group: Src Data: CancerNetwork (USA), March 20, 2023 News, 3pp – Name: Abstract Label: Abstract Group: Ab Data: Targeted immunotherapy agent Bria-IMT (SV-BR-1-GM) continued to yield clinical survival benefit in combination with retifanlimab (MGA012) in 11 patients with advanced, metastatic breast cancer who were enrolled in a phase 1/2 trial (NCT03328026) in 2021 or 2022, according to data published in a press release from BriaCell Therapeutics. Investigators reported a median progression-free survival (PFS) of 3.5 months, with 1 patient who continued to be progression free... |
PLink | https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsnbk&AN=190661711D3A4108 |
RecordInfo | BibRecord: BibEntity: Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 3 Titles: – TitleFull: Early Data Show Ongoing Benefit of Bria-IMT in Small Breast Cancer Population Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nicholas Wrigley IsPartOfRelationships: – BibEntity: Dates: – D: 20 M: 03 Text: March 20, 2023 Type: published Y: 2023 Titles: – TitleFull: CancerNetwork (USA) Type: main |
ResultId | 1 |